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Intractable Ventricular Tachycardia Treated with
Massive Countershock and Large Doses·
of Procainamide
J. T. MARSHALL, B. M. KENNELLY
SUMMARY
Ventricular tachycardia complicating myocardial infarction
is a dangerous condition requiring urgent therapy. A case
report describes the most challenging therapeutic problem
of ventricular tachycardia which we have encountered
over the past five years in the Coronary Intensive Care
Unit.
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CASE REPORT
The patient, a 65-year-old White male, was admitted to
the Coronary Intensive Care Unit a few hours after an
acute myocardial infarction. His first stay in the unit,
lasting 6 days, was complicated by sinus bradycardia,
ventricular extrasystoles, complete heart block (for which
a temporary transvenous pacemaker was inserted), cardiac
failure requiring treatment with digitalis and diuretics,
and the development of a systolic murmur compatible
with papillary muscle dysfunction. His heart block re-
gressed via a Wenckebach second-degree block, and by
the twelfth day after infarction he was in sinus brady-
cardia with a normal P-R interval and his temporary
pacemaker was removed.
Nineteen days after infarction, in a general medical
ward, he developed ventricular tachycardia at a rate of
II8/min. He suffered no distress, although his blood
pressure fell from 140 to 90 mmHg systolic. He was
readmitted to the Coronary Intensive Care Unit and his
digoxin therapy was discontinued immediately.
During the next 11 days, the following drugs were
used intravenously: lignocaine 200 mg over 5 min; Isoptin
10 mg over 5 min; procainamide I g over 50 min;
Eraldin 25 mg over 25 min; potassium 80 mEq/litre over
2 hours at a time when his serum potassium was 4,4 mEq/
litre; also quinidine 1 800 mg over 4 hours orally, which
produced QRS widening of 20%; bretylium tosylate up to
800 mg intramuscularly every 12 hours, which produced
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postural symptoms and nausea, despite his being kept at
bed rest; Epanutin I g intravenously over 6 hours, droperi-
dol 5 mg intramuscularly and magnesium sulphate 20 m] of
50% solution intravenously over 5 min; and combinations
of quinidine or procainamide with Eraldin.
In an attempt to increase the sinus node rate and
achieve sinus capture, atropine was given intravenously
without significant effect. Intravenous isoprenaline achieved
a fast sinus rate with sinus capture, but ventricular
tachycardia broke through as soon as the infusion rate
was reduced. .
During this period also, cardioversion using energies
up to 400 Wsec was unsuccessfully tried, both alone, and
immediately after 200 mg lignocaine intravenously. A
transvenous pacemaker was inserted into the right ven-
tricle, where overdrive ventricular pacing was successfully
achieved. The arrhythmia, however, broke through when-
ever the pacing rate was lowered below that of the
tachycardia. Paired ventricular pacing was then tried.
and the arrhythmia was controlled with a paced ventricular
rate of 180/min. Again, however, the arrhythmia broke
through whenever the paired pacing was discontinued.
After paired pacing for approximately 36 hours, the patient
went into ventricular fibrillation and was successfully
defibrillated into his original ventricular tachycardia
rhythm, and paired pacing was discontinued.
With a resectable left ventricular aneurysm in mind,
cardiac catheterisation was performed, which showed an
akinetic inferior left ventricular wall, with an otherwise
adequately contracting left ventricular muscle, but no
frank aneurysm. Left ventricular diastolic pressure during
the investigation was 26 - 43 mmHg. Coronary arterio-
graphy showed complete occlusion of the left circumflex
artery with severe patchy disease of both the left anterior
descending and the right coronary arteries.
By now the ventricular rate had gradually risen from
120 to 180/min at times (Fig. I), and cardiac failure had
developed. The blood urea had risen to 70 mg/lOO ml
with a serum creatinine of 2,4 mg/l00 m!. On the advice
of Dr Bernard Lown, 2 standard cardioverters were linked
in series and an 800 Wsec DC shock was adminjstered
under 90 mg of Valium sedation. The patient reverted to
sinus bradycardia with a current of injury persisting for
about 30 sec after the shock (Fig. 2).
Twelve hours later the ventricular tachycardia broke
through again, and it was thought that this was facilitated
by the underlying sinus bradycardia. Further, transiently
successful cardioversion was now achieved at lower ener-
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Fig. 1. Upper monitor lead ECG illustrates ventricular
tachycardia at onset at rate of lIS/min. The third and
eighth complexes are sinus captures. Lower monitor lead
ECG strip (different lead system) illustrates the faster
ventricular rate which gradually developed.
Fig. 2. Monitor lead ECG illustrating effect of first 800
Wsec DC countershock on SoT segments.
ies, usuaIJy in excess of 600 Wsec but, on occasion,
~quiring as little as 400 Wsec. Despite maintaining a
1st sinus rate with a combination of atropine and iso-
renaline, and subsequently with ventricular pacing, only
!lort-lived sinus capture resulted after each cardioversion
efore ventricular tachycardia broke through again.
Eighteen days after the onset of ventricular tachycardia.
le patient was digitalised and given procainamide via a
)ntinuous intravenous infusion at the rate of I g/h.
fter 5,15 mg of procainamide, sinus rhythm at a rate
f 60/min resulted. A heart rate of 88/min was then
maintained by ventricular pacing and procainamide, I g
every 4 hours orally. The patient, however, vomited, and
remained hypotensive and in cardiac failure with poor
urine output and a rising blood urea. The dose was
reduced, and finaIJy discontinued in the hope that· the
faster paced rate alone would prevent a recurrence of the
arrhythmia. Ventricular tachycardia, however, recurred,
and it required a further 6 g of procainamide over 6
hours intravenously to convert the patient to sinus rhythm.
Procainamide was now given via a constant intravenous
infusion, and gastro-intestinal side-effects no longer pre-
sented a problem.
By now it was evident that the arrhythmia could be
converted with large doses of procainamide but that
breakthrough occurred at a slow intrinsic sinus rate.
A permanent atrial pacemaker was therefore advised, as
preservation of appropriately timed atrial systole was
considered advantageous in the face of persistently poor
cardiac function. Twenty-seven days after the onset of
the ventricular tachycardia, a permanent atrial pacemaker
was implanted at thoracotomy. During surgery ventricular
tachycardia recurred and was again controlled with large
doses of intravenous procainamide. Paced atrial rhythm
with 2:1 A-V block was present postoperatively, but on
withdrawing the digitalis, this changed to paced atrial
rhythm with a normal P-R interval and I: I conduction.
The pa tient"s postoperative course was one of steady
improvement. His systoJic blood pressure rose to between
lOO - 140 mmHg, cardiac failure regressed, blood urea
feIJ to 20 mg/IOO ml and serum creatinine to 0,9 mg/IOO ml.
His mental state returned to· normal and his procainamide
was reduced to a maintenance dose of 500 mg every
6 hours which he was able to take orally without ill effects.
Thirty-nine days after the arrhythmia had first appeared,
the patient was intermittently in sinus rhythm above the
reserve rate of the pacemaker of 90/min, and he was
discharged from hospital with only s:ightly reduced effort
tolerance. In the course of the folJowing ]2 months of
follow-up, procainamide was withdrawn under care-
ful monitoring control without recurrence of arrhythmia.
On exercise he can accelerate his sinus rate above the
pre-set rate of 90/min of the pacemaker, suggesting that
his sinus node has recovered sufficiently to make his
pacemaker redundant.
DISCUSSION
The incidence of ventricular tachycardia folJowing acute
myocardial infarction has b~en variously reported as from
6 0 0 ' to 300/0' with a mortality of between 300~3.' and
67% '; with prolonged ventricular tachycardia having a
mortality as high as 72 °0 ." Ventricular tachycardia occurs
most commonly within 48 hours of infarction"" although
ventricular tachycardia of late onset is a well-recognised
occurrence'·· Bouvrain' reported 20% of ventricular tachy-
cardias occurring more than 3 weeks after infarction.
Factors such as fresh infarction, increased sensitivity to
catecholamines, hypoxia, acidosis, hypokalaemia, digitalis
toxicity and increased free fatty acids, have been implicated
in lat~ onset arrhythmias. No obvious cause was operative
in the patient described, although he had shown a
III
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complicated initial course with A-V block and left ventri-
cular failure, as is frequently seen in patients suffering
late-onset arrhythmias:" o
Therapy of ventricular tachycardia is fairly standardised,
and although control of paroxysmal tachycardia has
presented problems in some of our patients previously,
we have not experienced undue difficulty in breaking
attacks of ventricular tachycardia. In view of the failure of
seemingly acceptable doses of current anti-arrhythmics,
cardioversion, overdrive pacing and paired pacing, we
undertook cardiac catheterisation, including coronary
and left ventricular angiography, to look for a left ventri-
'cular aneurysm, resection of which may have aborted
the arrhythmia. Recent reports by DeSanctis et al." and
Ecker et al." describe the successful use of ventricular
aneurysmectomy with or without saphenous aortocoronary
bypass grafts, in the cure of drug-resistant late-onset ven-
tricular tachycardias after myocardial infarction. No clear
aneurysm was seen in our patient and no vessels were
suitable for bypass grafting.
Desperation, therefore, led to the use of high-energy
(800 Wsec) counteEhock on the advice of Or Eernard
Lown who had previously reported its successful use in
a case of resistant ventricular tachycardia." With the use
of liberal amounts of electrode paste only slight erythema
over the site of application of the cardioverter paddles
was produced, although a striking transient current of
injury was evident on the electrocardiogram which is not
believed to result in any permanent cardiac damage."
Procainamide in doses similar to those used initially
(100 mg every 5 min up to a total of I g) is a well-
established and effective therapy for ventricular tachy-
cardia in most patients. In the patient described, however,
it was clearly inadequate and massive doses were required
(5 - 6 g over 5 - 6 hours). eohn et al.' made this point quite
strongly, pointing out that many so-called drug-resistant
cases of ventricular tachycardia have received insufficient
procainamide, and recommended 50 - 100 mg{min intra-
venously for a minimum of 15 - 20 min. or until toxic
-
manifestations occur. If necessary, they advocated con-
tinuing the procainamide with concomitant use of vaso-
pressors if hypotension becomes a problem. Other authors
",,,.,, have also recommended very large doses of procain-
amide to break resistant ventricular tachycardia.
Finally, as has been shown bv other workers" the
arrhythmia was eventually suppres~ed by the combi~ation
of an anti-arrhythmic agent, plus artificial pacing to
overcome the persistent sinus bradycardia. With time, the
bradycardia has subsided and procainamide has been
successfully withdrawn. The reason for the prolonged
sinus node depression in this patient is unknown, but may
have been related to vascular interference at the time
of myocardial infarction, with subsequent delayed recovery.
We wish to thank the South African Medical Research
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